Early blood protein clues could identify children at risk of cardiometabolic disease
· Medical Xpressby Vanderbilt University Medical Center
edited by Sadie Harley, reviewed by Robert Egan
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Researchers at Vanderbilt Health, UTHealth Houston and the University of North Carolina at Chapel Hill have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that potentially can be reversed with a new class of weight-loss drugs widely used by adults.
Using cutting-edge advanced analytical techniques, the researchers defined a "signature" of circulating proteins in children and adolescents that mirrored molecular biomarkers associated with irreversible cardiovascular disease in adults.
Their findings, published in the journal Nature Metabolism, suggest there may be "a critical opportunity" to improve the health and longevity of young people, free of cardiovascular disease, through precision medicine.
How the protein signatures emerged
The study included 273 children and adolescents who participate in the Border Health Research Cohort in Cameron County, Texas, on the U.S.–Mexico border. More than a third had phenotypes (physical characteristics) of cardiovascular, kidney and metabolic disease, including obesity, higher-than-normal blood pressure, prediabetic insulin resistance and levels of lipids (fats) in the blood associated with an increased risk of heart disease.
From blood samples and other physical measures, the researchers estimated associations between levels of circulating proteins and disease-associated phenotypes. They used machine-learning approaches to identify proteomic "signatures" of CKMD.
Similar protein patterns were identified in 685 adults from the same Cameron County community and in more than 28,000 adults whose blood samples are stored in the UK Biobank in England, one of the world's largest repositories of genetic and other biological samples.
Promise tempered by treatment risks
Interestingly, levels of these disease-associated proteins in adults have been found to decline in response to therapy with semaglutide, a GLP-1 receptor agonist developed for type 2 diabetes that has become a popular treatment for obesity and weight management—in children as well as adults.
Between 2020 and 2023, pediatric prescriptions for GLP-1 receptor agonists increased by nearly 600%. Yet it is important to balance the benefits of such therapy with potential risks, the researchers cautioned.
Attempts to combat the rising tide of childhood obesity by promoting cardiovascular health through exercise, a healthy diet and, increasingly, weight-loss drugs and surgery have had limited success. "Yet our data suggest that we can and must redouble these efforts," they noted.
A window before symptoms appear
While additional research is needed to validate these results, the study suggests that proteomic signatures, by "opening a window into the earliest roots of cardiovascular disease at its most interruptible phase," may help identify children most at risk and therefore most likely to benefit from targeted therapy, the paper concluded.
The paper's co-corresponding authors are Ravi Shah, M.D., the Gottlieb C. Friesinger II Professor of Cardiovascular Medicine at Vanderbilt Health and co-director of the Vanderbilt Diabetes Center, and Kari North, Ph.D., professor at UTHealth Houston School of Public Health and director of the Border Health Research Center.
"Childhood is not simply a precursor to adult health," North said. "It is where the biology of adult cardiovascular disease is already taking place."
"Because many of the protein patterns we identified are potentially modifiable," Shah noted, "these findings suggest that the greatest opportunity to prevent heart disease may come decades before the first symptoms appear."
Publication details
Joshua M. Landman et al, Paediatric proteomic signatures of cardiometabolic disease-associated traits predict adult disease outcomes, Nature Metabolism (2026). DOI: 10.1038/s42255-026-01589-7
Journal information: Nature Metabolism
Key medical concepts
Clinical categories
PediatricsCardiologyChildren's healthEndocrinologyWeight managementLaboratory medicineCommon illnesses & Prevention Provided by Vanderbilt University Medical Center Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Early blood protein clues could identify children at risk of cardiometabolic disease (2026, September 13) retrieved 13 September 2026 from https://medicalxpress.com/news/2026-09-early-blood-protein-clues-children.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.